Calmesin-Mepha
Calmesin-Mepha is a medicine authorised by Swissmedic under authorisation number 53863. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 July 1996 and the authorisation is limited until 01 December 2026. ATC code R05DA09 places the medicine in the group Cough and cold preparations.
| Authorisation number | 53863 |
|---|---|
| Name | Calmesin-Mepha |
| Full name | Calmesin-Mepha, Sirup |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R05DA09 |
| First authorisation | 18 July 1996 |
| Authorisation validity | 01 December 2026 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Calmesin-Mepha, Sirup | B | 18 July 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 19 | 90 | ml | R05DA09 | 03.01.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Calmesin-Mepha authorised in Switzerland?
Yes. Calmesin-Mepha is authorised by Swissmedic under authorisation number 53863, data as of 01 September 2026. The authorisation is limited until 01 December 2026.
Which dispensing category does Calmesin-Mepha have?
Calmesin-Mepha is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Calmesin-Mepha?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.